4//SEC Filing
Schranz Jennifer 4
Accession 0001104659-20-131221
CIK 0001641640other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 8:21 PM ET
Size
4.5 KB
Accession
0001104659-20-131221
Insider Transaction Report
Form 4
Schranz Jennifer
Chief Medical Officer
Transactions
- Tax Payment
Ordinary Shares
2020-11-30$0.43/sh−301$129→ 167,240 total
Documents
Issuer
Nabriva Therapeutics plc
CIK 0001641640
Entity typeother
Related Parties
1- filerCIK 0001735382
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 8:21 PM ET
- Size
- 4.5 KB